Pharmacodynamic evaluation of selective antimuscarinic properties of pirenzepine in the rat.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001570:Benzodiazepinones / Q000494:pharmacology*; D004347:Drug Interactions; D005744:Gastric Acid / Q000378:metabolism; D008297:Male; D010095:Oxotremorine / Q000494:pharmacology; D010276:Parasympatholytics; D010879:Piperazines / Q000494:pharmacology*; D010890:Pirenzepine; D051381:Rats; D011919:Rats, Inbred Strains; D012472:Salivation / Q000187:drug effects
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D010276:Parasympatholytics; D010879:Piperazines; D010890:Pirenzepine; D010095:Oxotremorine; D001285:Atropine